Skip to main content
Journal cover image

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.

Publication ,  Journal Article
Strand, SH; Rivero-Gutiérrez, B; Houlahan, KE; Seoane, JA; King, LM; Risom, T; Simpson, LA; Vennam, S; Khan, A; Cisneros, L; Hardman, T; We, S ...
Published in: Cancer Cell
July 10, 2023

Duke Scholars

Published In

Cancer Cell

DOI

EISSN

1878-3686

Publication Date

July 10, 2023

Volume

41

Issue

7

Start / End Page

1381

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Strand, S. H., Rivero-Gutiérrez, B., Houlahan, K. E., Seoane, J. A., King, L. M., Risom, T., … West, R. B. (2023). Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell, 41(7), 1381. https://doi.org/10.1016/j.ccell.2023.06.002
Strand, Siri H., Belén Rivero-Gutiérrez, Kathleen E. Houlahan, Jose A. Seoane, Lorraine M. King, Tyler Risom, Lunden A. Simpson, et al. “Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell 41, no. 7 (July 10, 2023): 1381. https://doi.org/10.1016/j.ccell.2023.06.002.
Strand SH, Rivero-Gutiérrez B, Houlahan KE, Seoane JA, King LM, Risom T, et al. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2023 Jul 10;41(7):1381.
Strand, Siri H., et al. “Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.Cancer Cell, vol. 41, no. 7, July 2023, p. 1381. Pubmed, doi:10.1016/j.ccell.2023.06.002.
Strand SH, Rivero-Gutiérrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, Hardman T, Harmon B, Couch F, Gallagher K, Kilgore M, We S, DeMichele A, King T, McAuliffe PF, Nangia J, Lee J, Tseng J, Storniolo AM, Thompson AM, Gupta GP, Burns R, Veis DJ, DeSchryver K, Zhu C, Matusiak M, Wang J, Zhu SX, Tappenden J, Ding DY, Zhang D, Luo J, Jiang S, Varma S, Anderson L, Straub C, Srivastava S, Curtis C, Tibshirani R, Angelo RM, Hall A, Owzar K, Polyak K, Maley C, Marks JR, Colditz GA, Hwang ES, West RB. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2023 Jul 10;41(7):1381.
Journal cover image

Published In

Cancer Cell

DOI

EISSN

1878-3686

Publication Date

July 10, 2023

Volume

41

Issue

7

Start / End Page

1381

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences